Spectral Medical Inc. (EDTXF)
USD 0.58
(-0.12%)
USD 0.58
(-0.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -4.89 Million CAD | -597.76% |
| 2022 | 983 Thousand CAD | -19.43% |
| 2021 | 1.22 Million CAD | -17.18% |
| 2020 | 1.47 Million CAD | -33.59% |
| 2019 | 2.21 Million CAD | -36.12% |
| 2018 | 3.47 Million CAD | 4.3% |
| 2017 | 3.32 Million CAD | 17.26% |
| 2016 | 2.83 Million CAD | 17.27% |
| 2015 | 2.42 Million CAD | 9.55% |
| 2014 | 2.21 Million CAD | 22.44% |
| 2013 | 1.8 Million CAD | -1.96% |
| 2012 | 1.84 Million CAD | -7.35% |
| 2011 | 1.98 Million CAD | -7.45% |
| 2010 | 2.14 Million CAD | -12.26% |
| 2009 | 2.44 Million CAD | 10.47% |
| 2008 | 2.21 Million CAD | 1.14% |
| 2007 | 2.19 Million CAD | 36.96% |
| 2006 | 1.59 Million CAD | -71.17% |
| 2005 | 5.54 Million CAD | -19.18% |
| 2004 | 6.86 Million CAD | -24.15% |
| 2003 | 9.04 Million CAD | -13.16% |
| 2002 | 10.41 Million CAD | 25.92% |
| 2001 | 8.27 Million CAD | 6.08% |
| 2000 | 7.8 Million CAD | -8.24% |
| 1999 | 8.5 Million CAD | 107.32% |
| 1998 | 4.1 Million CAD | 173.33% |
| 1997 | 1.5 Million CAD | 150.0% |
| 1996 | 600 Thousand CAD | 20.0% |
| 1995 | 500 Thousand CAD | 150.0% |
| 1994 | 200 Thousand CAD | 100.0% |
| 1993 | 100 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -919 Thousand CAD | 10.17% |
| 2024 Q2 | -2.08 Million CAD | -126.77% |
| 2023 Q3 | 92 Thousand CAD | 268.0% |
| 2023 FY | -4.89 Million CAD | -597.76% |
| 2023 Q4 | -1.02 Million CAD | -1211.96% |
| 2023 Q1 | 393 Thousand CAD | -7.75% |
| 2023 Q2 | 25 Thousand CAD | -93.64% |
| 2022 Q1 | 336 Thousand CAD | 115.38% |
| 2022 Q2 | 62 Thousand CAD | -81.55% |
| 2022 Q3 | 159 Thousand CAD | 156.45% |
| 2022 FY | 983 Thousand CAD | -19.43% |
| 2022 Q4 | 426 Thousand CAD | 167.92% |
| 2021 Q2 | 363 Thousand CAD | -40.0% |
| 2021 FY | 1.22 Million CAD | -17.18% |
| 2021 Q4 | 156 Thousand CAD | 62.5% |
| 2021 Q3 | 96 Thousand CAD | -73.55% |
| 2021 Q1 | 605 Thousand CAD | 76.9% |
| 2020 Q2 | 338 Thousand CAD | -31.58% |
| 2020 FY | 1.47 Million CAD | -33.59% |
| 2020 Q4 | 342 Thousand CAD | 14.38% |
| 2020 Q1 | 494 Thousand CAD | -21.34% |
| 2020 Q3 | 299 Thousand CAD | -11.54% |
| 2019 Q2 | 818 Thousand CAD | 98.54% |
| 2019 Q1 | 412 Thousand CAD | -76.75% |
| 2019 Q4 | 628 Thousand CAD | 74.44% |
| 2019 FY | 2.21 Million CAD | -36.12% |
| 2019 Q3 | 360 Thousand CAD | -55.99% |
| 2018 Q1 | 1.07 Million CAD | 31.9% |
| 2018 FY | 3.47 Million CAD | 4.3% |
| 2018 Q4 | 1.77 Million CAD | 266.12% |
| 2018 Q3 | 484 Thousand CAD | 233.79% |
| 2018 Q2 | 145 Thousand CAD | -86.46% |
| 2017 Q4 | 812 Thousand CAD | 12.31% |
| 2017 Q1 | 874 Thousand CAD | 26.12% |
| 2017 Q2 | 920 Thousand CAD | 5.26% |
| 2017 Q3 | 723 Thousand CAD | -21.41% |
| 2017 FY | 3.32 Million CAD | 17.26% |
| 2016 Q1 | 834 Thousand CAD | 68.48% |
| 2016 Q2 | 717 Thousand CAD | -14.03% |
| 2016 Q4 | 693 Thousand CAD | 16.47% |
| 2016 Q3 | 595 Thousand CAD | -17.02% |
| 2016 FY | 2.83 Million CAD | 17.27% |
| 2015 Q2 | 655 Thousand CAD | -13.01% |
| 2015 Q1 | 753 Thousand CAD | 53.67% |
| 2015 FY | 2.42 Million CAD | 9.55% |
| 2015 Q4 | 495 Thousand CAD | -4.44% |
| 2015 Q3 | 518 Thousand CAD | -20.92% |
| 2014 Q4 | 490 Thousand CAD | -3.73% |
| 2014 Q1 | 594 Thousand CAD | 20.0% |
| 2014 Q2 | 617 Thousand CAD | 3.87% |
| 2014 Q3 | 509 Thousand CAD | -17.5% |
| 2014 FY | 2.21 Million CAD | 22.44% |
| 2013 Q1 | 514 Thousand CAD | 13.97% |
| 2013 Q4 | 495 Thousand CAD | 14.58% |
| 2013 Q3 | 432 Thousand CAD | 18.68% |
| 2013 Q2 | 364 Thousand CAD | -29.18% |
| 2013 FY | 1.8 Million CAD | -1.96% |
| 2012 Q4 | 451 Thousand CAD | -3.63% |
| 2012 FY | 1.84 Million CAD | -7.35% |
| 2012 Q3 | 468 Thousand CAD | 5.41% |
| 2012 Q2 | 444 Thousand CAD | -7.11% |
| 2012 Q1 | 478 Thousand CAD | -3.04% |
| 2011 Q4 | 493 Thousand CAD | 27.72% |
| 2011 Q2 | 564 Thousand CAD | 3.68% |
| 2011 FY | 1.98 Million CAD | -7.45% |
| 2011 Q1 | 544 Thousand CAD | 19.3% |
| 2011 Q3 | 386 Thousand CAD | -31.56% |
| 2010 Q4 | 456 Thousand CAD | -21.92% |
| 2010 Q2 | 523 Thousand CAD | -10.45% |
| 2010 FY | 2.14 Million CAD | -12.26% |
| 2010 Q1 | 584 Thousand CAD | -2.01% |
| 2010 Q3 | 584 Thousand CAD | 11.66% |
| 2009 Q3 | 583 Thousand CAD | -4.43% |
| 2009 Q1 | 658 Thousand CAD | 5.28% |
| 2009 Q2 | 610 Thousand CAD | -7.29% |
| 2009 FY | 2.44 Million CAD | 10.47% |
| 2009 Q4 | 596 Thousand CAD | 2.23% |
| 2008 Q1 | 464 Thousand CAD | 8.67% |
| 2008 Q4 | 625 Thousand CAD | 17.92% |
| 2008 Q3 | 530 Thousand CAD | -11.07% |
| 2008 Q2 | 596 Thousand CAD | 28.45% |
| 2008 FY | 2.21 Million CAD | 1.14% |
| 2007 FY | 2.19 Million CAD | 36.96% |
| 2007 Q2 | 571 Thousand CAD | -7.31% |
| 2007 Q4 | 427 Thousand CAD | -23.48% |
| 2007 Q3 | 558 Thousand CAD | -2.28% |
| 2007 Q1 | 616 Thousand CAD | 0.0% |
| 2006 FY | 1.59 Million CAD | -71.17% |
| 2006 Q2 | 497 Thousand CAD | -12.65% |
| 2006 Q1 | 569 Thousand CAD | -32.18% |
| 2006 Q3 | 440 Thousand CAD | -11.47% |
| 2005 Q3 | 1.2 Million CAD | -0.5% |
| 2005 Q4 | 839 Thousand CAD | -30.43% |
| 2005 FY | 5.54 Million CAD | -19.18% |
| 2005 Q1 | 1.11 Million CAD | -15.19% |
| 2005 Q2 | 1.21 Million CAD | 8.5% |
| 2004 Q1 | 1.75 Million CAD | -9.37% |
| 2004 FY | 6.86 Million CAD | -24.15% |
| 2004 Q4 | 1.31 Million CAD | -11.19% |
| 2004 Q3 | 1.48 Million CAD | -8.91% |
| 2004 Q2 | 1.62 Million CAD | -6.97% |
| 2003 FY | 9.04 Million CAD | -13.16% |
| 2003 Q2 | 1.66 Million CAD | 4.93% |
| 2003 Q3 | 1.52 Million CAD | -8.31% |
| 2003 Q4 | 1.93 Million CAD | 26.87% |
| 2003 Q1 | 1.58 Million CAD | -41.32% |
| 2002 FY | 10.41 Million CAD | 25.92% |
| 2002 Q4 | 2.69 Million CAD | -2.14% |
| 2002 Q3 | 2.75 Million CAD | 36.72% |
| 2002 Q2 | 2.01 Million CAD | 2.96% |
| 2002 Q1 | 1.95 Million CAD | -4.95% |
| 2001 FY | 8.27 Million CAD | 6.08% |
| 2001 Q1 | 2.07 Million CAD | -14.21% |
| 2001 Q2 | 4.66 Million CAD | 124.41% |
| 2001 Q3 | 1.74 Million CAD | -62.63% |
| 2001 Q4 | 2.05 Million CAD | 18.2% |
| 2000 FY | 7.8 Million CAD | -8.24% |
| 2000 Q3 | 1.98 Million CAD | 10.39% |
| 2000 Q4 | 2.42 Million CAD | 21.84% |
| 2000 Q1 | 2.2 Million CAD | -8.33% |
| 2000 Q2 | 1.8 Million CAD | -18.18% |
| 1999 Q2 | 1.5 Million CAD | -44.44% |
| 1999 Q4 | 2.4 Million CAD | 60.0% |
| 1999 FY | 8.5 Million CAD | 107.32% |
| 1999 Q1 | 2.7 Million CAD | 22.73% |
| 1999 Q3 | 1.5 Million CAD | 0.0% |
| 1998 Q3 | 1.5 Million CAD | -25.0% |
| 1998 Q4 | 2.2 Million CAD | 46.67% |
| 1998 Q2 | 2 Million CAD | -9.09% |
| 1998 Q1 | 2.2 Million CAD | 37.5% |
| 1998 FY | 4.1 Million CAD | 173.33% |
| 1997 FY | 1.5 Million CAD | 150.0% |
| 1997 Q4 | 1.6 Million CAD | 60.0% |
| 1997 Q3 | 1 Million CAD | 100.0% |
| 1997 Q1 | 500 Thousand CAD | 0.0% |
| 1997 Q2 | 500 Thousand CAD | 0.0% |
| 1996 Q1 | 100 Thousand CAD | 0.0% |
| 1996 Q4 | 500 Thousand CAD | 25.0% |
| 1996 FY | 600 Thousand CAD | 20.0% |
| 1996 Q3 | 400 Thousand CAD | 300.0% |
| 1996 Q2 | 100 Thousand CAD | 0.0% |
| 1995 FY | 500 Thousand CAD | 150.0% |
| 1995 Q4 | 100 Thousand CAD | -50.0% |
| 1995 Q1 | 100 Thousand CAD | 0.0% |
| 1995 Q3 | 200 Thousand CAD | 0.0% |
| 1995 Q2 | 200 Thousand CAD | 100.0% |
| 1994 Q1 | 100 Thousand CAD | 0.0% |
| 1994 Q3 | 300 Thousand CAD | 200.0% |
| 1994 Q4 | 100 Thousand CAD | -66.67% |
| 1994 FY | 200 Thousand CAD | 100.0% |
| 1994 Q2 | 100 Thousand CAD | 0.0% |
| 1993 Q4 | 100 Thousand CAD | 0.0% |
| 1993 FY | 100 Thousand CAD | 0.0% |
| 1993 Q1 | -27.7 Thousand CAD | -121.7% |
| 1993 Q3 | 100 Thousand CAD | 0.0% |
| 1993 Q2 | 100 Thousand CAD | 460.91% |
| 1992 Q3 | 124.78 Thousand CAD | 4.32% |
| 1992 Q2 | 119.61 Thousand CAD | 0.0% |
| 1992 Q4 | 127.7 Thousand CAD | 2.34% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | -2435.233% |
| Arrayit Corporation | 2.57 Million USD | 290.015% |
| Atlantic International Corp. | -154.23 Thousand USD | -3072.452% |
| Biocept, Inc. | -2.58 Million USD | -89.504% |
| Bioqual, Inc. | 7.42 Million USD | 165.862% |
| CardioGenics Holdings Inc | - USD | Infinity% |
| DermTech, Inc. | 276 Thousand USD | 1872.826% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.073% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 372.729% |
| iMD Companies, Inc. | -23.63 Thousand USD | -20600.597% |
| IDenta Corp. | 662.97 Thousand USD | 838.037% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 121.234% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | 6407.77% |
| InVitro International | 635.98 Thousand USD | 869.358% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 174.554% |
| Many Bright Ideas Technologies Inc. | - USD | Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 547.796% |
| NovelStem International Corp. | 12 Thousand USD | 40875.0% |
| Optigenex Inc. | -102.96 Thousand USD | -4652.054% |
| PharmChem, Inc. | 3.9 Million USD | 225.321% |
| Proteome Sciences plc | 2.09 Million USD | 333.374% |
| Response Genetics, Inc | 3.94 Million USD | 224.125% |
| Rennova Health, Inc. | 6.26 Million USD | 178.06% |
| RushNet, Inc. | 1.1 Million USD | 542.96% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 671.229% |
| Stella Diagnostics Inc. | - USD | Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | -1111.898% |
| Todos Medical Ltd. | 4.31 Million USD | 213.527% |